Goldman Sachs Maintains Buy on Henry Schein

Goldman Sachs is out with its report today on Henry Schein HSIC, maintaining Buy. In a note to clients, Goldman Sachs writes, "We hosted and Q&A session and investor dinner with Steven Paladino, EVP and CFO and Ferdinand Jahnel, VP and Treasurer where commentary on the company's key end-markets remains positive. Although timing remains fluid, the CFO was 'bullish' about an acceleration in demand of dental equipment." Shares of HSIC closed Tuesday at $68.80.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingsGoldman SachsHealth CareHealth Care Distributorshenry schein
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!